Platelet Lysate Nebulization Protocol for the Treatment of COVID-19 and Its Sequels: Proof of Concept and Scientific Rationale

Total Page:16

File Type:pdf, Size:1020Kb

Platelet Lysate Nebulization Protocol for the Treatment of COVID-19 and Its Sequels: Proof of Concept and Scientific Rationale International Journal of Molecular Sciences Article Platelet Lysate Nebulization Protocol for the Treatment of COVID-19 and Its Sequels: Proof of Concept and Scientific Rationale Maider Beitia 1,†, Diego Delgado 1,†, Pello Sánchez 1, Ana Vallejo de la Cueva 2,3 , José Ramón Cugat 4 and Mikel Sánchez 1,* 1 Advanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain; [email protected] (M.B.); [email protected] (D.D.); [email protected] (P.S.) 2 Care and Technology for Critical and Postcritical Patients Research Group, Bioaraba, 01009 Vitoria-Gasteiz, Spain; [email protected] 3 Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain 4 Pneumology Service, Sant Joan de Déu de Manresa Hospital, 08243 Manresa, Spain; [email protected] * Correspondence: [email protected]; Tel.: +34-945-252077 † M. Beitia and D. Delgado have contributed equally to this manuscript. Abstract: One of the most severe effects of coronavirus disease 2019 (COVID-19) is lung disorders Citation: Beitia, M.; Delgado, D.; such as acute respiratory distress syndrome. In the absence of effective treatments, it is necessary to Sánchez, P.; Vallejo de la Cueva, A.; search for new therapies and therapeutic targets. Platelets play a fundamental role in respiratory Cugat, J.R.; Sánchez, M. Platelet disorders resulting from viral infections, being the first line of defense against viruses and essential Lysate Nebulization Protocol for the in maintaining lung function. The direct application of platelet lysate (PL) obtained from the platelet- Treatment of COVID-19 and Its rich plasma of healthy donors could help in the improvement of the patient due its anti-inflammatory, Sequels: Proof of Concept and immunomodulatory, antifibrotic, and repairing effects. This work evaluates PL nebulization by Scientific Rationale. Int. J. Mol. Sci. analyzing its levels of growth factors and its biological activity on lung fibroblast cell cultures, 2021, 22, 1856. https://doi.org/ besides describing a scientific basis for its use in this kind of pathology. The data of the work 10.3390/ijms22041856 suggest that the molecular levels and biological activity of the PL are maintained after nebulization. Academic Editors: George Airway administration would allow acting directly on the lung tissue modulating inflammation and J. Kontoghiorghes, Christina stimulating reparative processes on key structures such as the alveolocapillary barrier, improving the N. Kontoghiorghe and disease and sequels. The protocol developed in this work is a first step for the study of nebulized PL Annita Kolnagou both in animal experimentation and in clinical trials. Received: 22 December 2020 Keywords: platelet-rich plasma; platelet lysate; COVID-19; nebulization; platelet; growth factors Accepted: 11 February 2021 Published: 12 February 2021 Publisher’s Note: MDPI stays neutral 1. Introduction with regard to jurisdictional claims in A new coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS- published maps and institutional affil- CoV-2) was identified in China at the end of 2019 [1]. It is transmitted by saliva droplets iations. and aerosols emitted by infected individuals [2]. People infected by this virus can progress either asymptomatically or develop the coronavirus disease 2019 (COVID-19) that can cause acute respiratory distress syndrome (ARDS) and/or cardiovascular complications among others which, in the most severe cases, might eventually lead to death [3–7]. Additionally, Copyright: © 2021 by the authors. COVID-19 frequently produces sequels such as pulmonary fibrosis, which progressively Licensee MDPI, Basel, Switzerland. reduces the respiratory capacity of patients and, hence, profoundly limits their quality of This article is an open access article life [8,9]. Lastly, it is important to take into consideration the complications that can arise distributed under the terms and when generating immunity, since as in the previous SARS-associated coronavirus, antibod- conditions of the Creative Commons ies against the patient’s own cells could be generated, developing immunopathological Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ disorders [10]. 4.0/). Int. J. Mol. Sci. 2021, 22, 1856. https://doi.org/10.3390/ijms22041856 https://www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 2 of 18 can arise when generating immunity, since as in the previous SARS-associated corona- virus, antibodies against the patient’s own cells could be generated, developing immuno- pathological disorders [10]. While waiting for the effect of the new vaccines, there is no effective treatment to deal with this health emergency, and therefore, there is an urgent need for new treatments. The Int. J. Mol. Sci. 2021, 22, 1856 2 of 18 design of new therapies must be focused not only on the elimination of the virus but also on the recovery of the affected lung tissue and the avoidance or reduction of the severe sequels. In that sense, treatments based on regenerative medicine and specifically platelet- While waiting for the effect of the new vaccines, there is no effective treatment to rich plasma (PRP) could be suitable and effective to tackle this disease. deal with this health emergency, and therefore, there is an urgent need for new treatments. Platelet-rich plasma,The a designbiological of new therapy therapies approved mustbe by focused regulatory not onlyagencies, on the is elimination based of the virus on the concentration ofbut the also platelets on the recoverypresent in of theblood affected [11].lung Platelets tissue are and small the avoidance anucleate or reduction of the cells derived from megakaryocytessevere sequels. whose In that biosynthesis sense, treatments takes based place on in regenerative both bone marrow medicine and specifically and lungs [12,13]. Theirplatelet-rich actions rely plasma not only (PRP) on could the regulation be suitable of and thrombosis effective to but tackle also this on disease. the biological activity of thePlatelet-rich complex pool plasma, of chemokines, a biological therapy cytokines approved, and growth by regulatory factors agencies, is based released from the plateleton granules, the concentration which are of the able platelets to induce present biological in blood processes [11]. Platelets of pro- are small anucleate liferative, antifibrotic, andcells anti derived-inflammatory from megakaryocytes nature. Thus, whose they biosynthesis have been classically takes place con- in both bone marrow and lungs [12,13]. Their actions rely not only on the regulation of thrombosis but also sidered the principal responsible of hemostasis, wound healing, anti-inflammatory activ- on the biological activity of the complex pool of chemokines, cytokines, and growth ities, and tissue repair,factors among released others from [14] the. However, platelet granules, recent whichresearch are ableworks to induce have biologicalalso processes of shown an association ofproliferative, platelets with antifibrotic, antiviral andactivities anti-inflammatory as well as lung nature. biology Thus, and they phys- have been classically iology [15]. Even if plateletsconsidered are of the great principal importance responsible to activate of hemostasis, antiviral wound defense, healing, it has anti-inflammatory been revealed that virusesactivities, can al andso negatively tissue repair, affect among platelets others [by14 ].translating However, viral recent RNA research works have into proteins, which leadsalso to shown a conversion an association of healthy of platelets platelets with into antiviral detrimental activities ones as well [16] as. lung biology and Considering the mentionedphysiology pathophysiology [15]. Even if platelets generated are of great by COVID importance-19 and to activate other res- antiviral defense, it piratory infections, PRPhas-based been therapies revealed that could viruses counteract can also the negatively loss of affecthealthy platelets platelets by translating by viral RNA into proteins, which leads to a conversion of healthy platelets into detrimental ones [16]. a local administration of healthy donors’ platelet content and consequently, retrieve and Considering the mentioned pathophysiology generated by COVID-19 and other res- amplify their biologicalpiratory effects, infections,boosting the PRP-based regeneration therapies of damaged could counteract lung tissue the loss and of the healthy platelets by reduction of fibrosis. Asa localthat PRP administration must reach of healthythe alveoli donors’ in the platelet lungs, content we propose and consequently, its in- retrieve and haled application into theamplify respiratory their biological system by effects, the aspiration boosting theof allogenic regeneration nebulized of damaged PRP. lung tissue and Therefore, the aim of thisthe work reduction is to of develop fibrosis. a As protocol that PRP to must nebulize reach PRP the alveoli and to in evaluate the lungs, we propose its its composition and bioactivityinhaled application in order to into apply the respiratory it in COVID system-19 bypatients the aspiration to boost of the allogenic re- nebulized PRP. covery of the injured areaTherefore, as well the as aimto prevent of this work lung is fibrosis to develop sequels. a protocol In addition, to nebulize a scien- PRP and to evaluate its tific basis for its use in thiscomposition kind of pathologies and bioactivity is indescribed. order
Recommended publications
  • US 2017/0020926 A1 Mata-Fink Et Al
    US 20170020926A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2017/0020926 A1 Mata-Fink et al. (43) Pub. Date: Jan. 26, 2017 (54) METHODS AND COMPOSITIONS FOR 62/006,825, filed on Jun. 2, 2014, provisional appli MMUNOMODULATION cation No. 62/006,829, filed on Jun. 2, 2014, provi sional application No. 62/006,832, filed on Jun. 2, (71) Applicant: RUBIUS THERAPEUTICS, INC., 2014, provisional application No. 61/991.319, filed Cambridge, MA (US) on May 9, 2014, provisional application No. 61/973, 764, filed on Apr. 1, 2014, provisional application No. (72) Inventors: Jordi Mata-Fink, Somerville, MA 61/973,763, filed on Apr. 1, 2014. (US); John Round, Cambridge, MA (US); Noubar B. Afeyan, Lexington, (30) Foreign Application Priority Data MA (US); Avak Kahvejian, Arlington, MA (US) Nov. 12, 2014 (US) ................. PCT/US2O14/0653O4 (21) Appl. No.: 15/301,046 Publication Classification (22) PCT Fed: Mar. 13, 2015 (51) Int. Cl. A6II 35/28 (2006.01) (86) PCT No.: PCT/US2O15/02O614 CI2N 5/078 (2006.01) (52) U.S. Cl. S 371 (c)(1), CPC ............. A61K 35/28 (2013.01); C12N5/0641 (2) Date: Sep. 30, 2016 (2013.01): CI2N 5/0644 (2013.01); A61 K Related U.S. Application Data 2035/122 (2013.01) (60) Provisional application No. 62/059,100, filed on Oct. (57) ABSTRACT 2, 2014, provisional application No. 62/025,367, filed on Jul. 16, 2014, provisional application No. 62/006, Provided are cells containing exogenous antigen and uses 828, filed on Jun. 2, 2014, provisional application No.
    [Show full text]
  • Human Platelet Lysate As a Functional Substitute for Fetal Bovine Serum in the Culture of Human Adipose Derived Stromal/Stem Cells
    Brief Report Human Platelet Lysate as a Functional Substitute for Fetal Bovine Serum in the Culture of Human Adipose Derived Stromal/Stem Cells Mathew Cowper 1,†, Trivia Frazier 1,2,3, Xiying Wu 2,3, Lowry Curley 2,4, Michelle H. Ma 3, Omair A. Mohuiddin 1, Marilyn Dietrich 5, Michelle McCarthy 1, Joanna Bukowska 1,6 and Jeffrey M. Gimble 1,2,3,* 1 School of Medicine, Tulane University, New Orleans, LA 70112, USA 2 LaCell LLC, New Orleans, LA 70148, USA 3 Obatala Sciences Inc., New Orleans, LA 70148, USA 4 Axosim Sciences Inc., New Orleans, LA 70803, USA 5 Louisiana State University School of Veterinary Medicine, Baton Rouge, LA 70803, USA 6 Institute for Animal Reproduction and Food Research, Polish Academy of Science, 10-748 Olsztyn, Poland * Correspondence: [email protected]; Tel.: 1-(504)-300-0266 † Current Affiliations: Department of Urology, Bowman Gray School of Medicine, Wake Forest University, Winston Salem, NC 27101, USA. Received: 15 May 2019; Accepted: 9 July 2019; Published: 15 July 2019 Abstract: Introduction: Adipose derived stromal/stem cells (ASCs) hold potential as cell therapeutics for a wide range of disease states; however, many expansion protocols rely on the use of fetal bovine serum (FBS) as a cell culture nutrient supplement. The current study explores the substitution of lysates from expired human platelets (HPLs) as an FBS substitute. Methods: Expired human platelets from an authorized blood center were lysed by freeze/thawing and used to examine human ASCs with respect to proliferation using hematocytometer cell counts, colony forming unit- fibroblast (CFU-F) frequency, surface immunophenotype by flow cytometry, and tri-lineage (adipocyte, chondrocyte, osteoblast) differentiation potential by histochemical staining.
    [Show full text]
  • Review Article the Roles of Platelets in Inflammation, Immunity, Wound Healing and Malignancy
    Int J Clin Exp Med 2016;9(3):5347-5358 www.ijcem.com /ISSN:1940-5901/IJCEM0021296 Review Article The roles of platelets in inflammation, immunity, wound healing and malignancy Ymer H Mekaj1,2 1Institute of Pathophysiology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo; 2Department of Hemostasis and Thrombosis, National Blood Transfusion Center of Kosovo, Prishtina, Kosovo Received December 6, 2015; Accepted March 10, 2016; Epub March 15, 2016; Published March 30, 2016 Abstract: The roles of platelets as essential effector cells in hemostasis have been known for over a century. Platelets also have many other functions, which are facilitated by their complex morphological structures and their ability to synthesize and store a variety of biochemical substances. These substances are released via the platelet release re- action in response to tissue/cell damage. The aim of the current study was to review the reported functions of plate- lets in inflammation, immunity, wound healing and malignancy. For this purpose, we used relevant data from the latest numerous scientific studies, including review articles, and original research articles. Platelets physiologically respond to inflammation by recruiting inflammatory cells to repair and resolve injuries. This response is facilitated by the ability of platelets to promote vascular permeability under inflammatory conditions. Platelets have critical roles in innate and adaptive immune responses and extensively interact with endothelial cells, various pathogens, and almost all known immune cell types, including neutrophils, monocytes, macrophages and lymphocytes. Additionally, platelets affect wound healing by integrating complex cascades between their mediators, which include multiple cytokines, transforming growth factors, platelet growth factors, and vascular endothelial growth factors, among oth- ers.
    [Show full text]
  • The Expanding Horizons in Thrombosis and Hemostasis
    The Expanding Horizons in Thrombosis and Hemostasis Vivian Xiaoyan Du The Expanding Horizons in Thrombosis and Hemostasis Thesis University Utrecht ISBN: 978-90-8891-881-0 Cover design: Andrea Almering Layout: Vivian X. Du Printing: Uitgeverij BOXPress Copy right © X.Du, Utrecht 2014 The Expanding Horizons in Thrombosis and Hemostasis De Uitbreiding van de Horizon van Trombose en Hemostase (met een samenvatting in het Nederlands) 血栓与凝血新进展 (含中文概要) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof. dr. G. J. van der Zwaan, ingevolge het besluit van het collage voor promoties in het openbaar te verdedigen op maandag 16 juni 2014 des middags te 2.30 uur door Xiaoyan Du geboren op 23 september 1980 te Dongping county, China Promotor: Prof. dr. Ph. G. de Groot Co-promotor: Dr. B. de Laat The studies described in this thesis were supported by a grant from Sanquin Blood Supply awarded to Dr. Bas de Laat . Financial support by the Netherlands Heart Foundation for the publication of this thesis is gratefully acknowledged. Financial support by Synapse B.V. and Phenom-World for publication of this thesis is gratefully acknowledged. Additional financial support by Stago BNL, CASLO ApS, Bayer B.V. and ChipSoft B.V. is gratefully acknowledged. “As far as we can discern, the sole purpose of human existence is to kindle a light in the darkness of mere being.” Carl Jung To Iwan My father Pa en Ma Fernhout Dear Uncle and Aunt Du Beoordelingscommissie: prof. dr. J. A. G. van Strijp prof.
    [Show full text]
  • Pages 269-315) Effects DOI: of 10.22203/Ecm.V041a19platelet Products on Bio-Physiology ISSN of BM-Mscs1473-2262
    EuropeanJ Vun et al. Cells and Materials Vol. 41 2021 (pages 269-315) Effects DOI: of 10.22203/eCM.v041a19platelet products on bio-physiology ISSN of BM-MSCs1473-2262 THE IN VITRO EFFECTS OF PLATELET PRODUCTS ON THE BIOPHYSIOLOGICAL FUNCTIONS OF HUMAN BONE MARROW MESENCHYMAL STROMAL CELLS: A SYSTEMATIC REVIEW J. Vun1,2,3,*, M. Panteli1,2,3, E. Jones2 and P.V. Giannoudis1,2,3,4 1 Academic Department of Trauma and Orthopaedics, School of Medicine, University of Leeds, Leeds, UK 2 Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK 3 Leeds Orthopaedic and Trauma Sciences, Leeds General Infirmary, University of Leeds, Leeds, UK 4 NIHR Leeds Biomedical Research Centre, Chapel Allerton Hospital, Leeds, UK Abstract Platelet products (PP) and bone-marrow aspirate are popular sources of osteoinductive signalling molecules and osteogenic bone marrow mesenchymal stromal cells (BM-MSCs) used in the treatment of impaired bone healing. However, the combined use of PP and BM-MSCs in clinical studies has reported mixed results. Understanding the cellular and molecular interactions between PP and BM-MSCs plays the important role of guiding future research and clinical application. This systematic review investigates the effects of PP on the biophysiological functions of BM-MSCs in in vitro human studies, including (i) proliferation, (ii) migration, (iii) differentiation, (iv) growth factor/cytokine/protein expression, (v) immunomodulation, (vi) chemotactic effect on haematopoietic stem cells, (vii) response to apoptotic stress, and (viii) gene expression.In vitro studies in human have demonstrated the multi-faceted ‘priming effect’ of PP on the biophysiological functions of BM-MSCs.
    [Show full text]
  • Platelets Kill Circulating Parasites of All Major Plasmodium Species in Human Malaria
    From www.bloodjournal.org by guest on November 3, 2018. For personal use only. Regular Article PLATELETS AND THROMBOPOIESIS Platelets kill circulating parasites of all major Plasmodium species in human malaria Steven Kho,1 Bridget E. Barber,1,2 Edison Johar,3 Benediktus Andries,4 Jeanne R. Poespoprodjo,4-6 Enny Kenangalem,4,5 Kim A. Piera,1 Anna Ehmann,3 Ric N. Price,1,7 Timothy William,2,8,9 Tonia Woodberry,1 Simon Foote,3 Gabriela Minigo,1 Tsin W. Yeo,1,2 Matthew J. Grigg,1,2 Nicholas M. Anstey,1,2,* and Brendan J. McMorran3,* 1Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia; 2Infectious Diseases Society Sabah- Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Sabah, Malaysia; 3Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia; 4Timika Malaria Research Programme, Papuan Health and Community Development Foundation, Timika, Papua, Indonesia; 5Rumah Sakit Umum Daerah Kabupaten Mimika, Timika, Papua, Indonesia; 6Department of Paediatrics, University of Gadjah Mada, Yogyakarta, Indonesia; 7Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Jesselton Medical Centre, Kota Kinabalu, Sabah, Malaysia; and 9Clinical Research Centre, Queen Elizabeth Hospital, Kota Kinabalu, Sabah, Ministry of Health, Malaysia KEY POINTS Platelets are understood to assist host innate immune responses against infection, although direct evidence of this function in any human disease, including malaria, is unknown. Here we l Platelets directly – fl interact with and characterized platelet erythrocyte interactions by microscopy and ow cytometry in patients kill circulating with malaria naturally infected with Plasmodium falciparum, Plasmodium vivax, Plasmodium Plasmodium parasites malariae,orPlasmodium knowlesi.
    [Show full text]
  • Scale up of Platelet Production from Human Pluripotent Stem Cells for Developing Targeted Therapies: Advances and Challenges
    CELL & GENE THERAPY INSIGHTS STRATEGIES FOR SCALE-UP & SCALE-OUT EXPERT INSIGHT Scale up of platelet production from human pluripotent stem cells for developing targeted therapies: advances and challenges Jonathan N Thon & Sven M Karlsson Without question, the future of regenerative medicine is in the scalable production of transfusable human tissues for therapeutic use. Platelets will be among the first of these stem-cell based therapeutic tissues to be developed and adopted for clinical use, most notably because they are anucleate and can be safely irradiated to substantially reduce the risk of teratoma development and other cell contaminants. Furthermore, plate- lets are short-lived, well characterized, easily transplanted, are not re- quired to be autologous, and support a larger than $20 billion per year global market that relies entirely on human volunteer donors. While we are within a decade of realizing the potential of stem cell-based therapeu- tics, this was not obvious only several years ago. This article identifies the major logistical challenges associated with commercially scaling platelet production for therapeutic use and our experiential insights into translat- ing this technology to the clinic. Submitted for review: Sep 6 2017 u Published: Nov XX 2017 While platelets are primarily re- immunity [1–6]. Among the stem be safely irradiated to kill any con- sponsible for clot formation at sites cell-based therapeutic landscape, taminating nucleated cells, thereby of active hemorrhage, it is becom- platelets are an ideal early
    [Show full text]
  • Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: an in Vitro Study
    International Journal of Molecular Sciences Article Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: An In Vitro Study Franka Klatte-Schulz 1,*,†, Tanja Schmidt 1,† ID , Melanie Uckert 1, Sven Scheffler 2, Ulrich Kalus 3, Markus Rojewski 4,5, Hubert Schrezenmeier 4,5, Axel Pruss 3 and Britt Wildemann 1 ID 1 Julius Wolff Institute, Berlin-Brandenburger Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 13353 Berlin, Germany, [email protected] (T.S.); [email protected] (M.U.); [email protected] (B.W.) 2 Sporthopaedicum Berlin, 10627 Berlin, Germany; sven.scheffl[email protected] 3 Institute of Transfusion Medicine, Tissue Bank, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany; [email protected] (U.K.); [email protected] (A.P.) 4 Institute for Transfusion Medicine, University Hospital Ulm, 89081 Ulm, Germany; [email protected] (M.R.); [email protected] (H.S.) 5 Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Donation Service, 89081 Ulm, Germany * Correspondence: [email protected]; Tel.: +49-30-450-559058 † These authors contributed equally to this work. Received: 13 December 2017; Accepted: 8 January 2018; Published: 10 January 2018 Abstract: The poor healing potential of tendons is still a clinical problem, and the use of Platelet Rich Plasma (PRP) was hypothesized to stimulate healing. As the efficacy of PRPs remains unproven, platelet lysate (PL) could be an alternative with its main advantages of storage and characterization before use.
    [Show full text]
  • A Therapy-Grade Protocol for Differentiation of Pluripotent Stem
    Luzzani et al. Stem Cell Research & Therapy 2015, 6:6 http://stemcellres.com/content/6/1/6 RESEARCH Open Access A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement Carlos Luzzani1*, Gabriel Neiman1, Ximena Garate1, María Questa1, Claudia Solari2, Darío Fernandez Espinosa1, Marcela García3, Ana Lía Errecalde3, Alejandra Guberman2,4, María Elida Scassa1, Gustavo Emilio Sevlever1, Leonardo Romorini1,4 and Santiago Gabriel Miriuka1,3,4* Abstract Introduction: Mesenchymal stem cells (MSCs) are a promising source of cells for regenerative therapies. Although they can be isolated easily from several tissues, cell expansion is limited since their properties are lost with successive passages. Hence, pluripotent derived MSCs (PD-MSCs) arise as a suitable alternative for MSC production. Nevertheless, at present, PD-MSC derivation protocols are either expensive or not suitable for clinical purposes. Methods: In this work we present a therapy-grade, inexpensive and simple protocol to derive MSCs from pluripotent stem cells (PSCs) based on the use of platelet lysate (PL) as medium supplement. Results: We showed that the PD-MSCPL expressed multiple MSC markers, including CD90, CD73, CD105, CD166, and CD271, among others. These cells also show multilineage differentiation ability and immunomodulatory effects on pre-stimulated lymphocytes. Thorough characterization of these cells showed that a PD-MSCPL resembles an umbilical cord (UC) MSC and differs from a PSC in surface marker and extracellular matrix proteins and integrin expression. Moreover, the OCT-4 promoter is re-methylated with mesenchymal differentiation comparable with the methylation levels of UC-MSCs and fibroblasts. Lastly, the use of PL-supplemented medium generates significantly more MSCs than the use of fetal bovine serum.
    [Show full text]
  • Journal of Blood Group Serology and Molecular Genetics Volume 30, Number 3, 2014 CONTENTS
    Journal of Blood Group Serology and Molecular Genetics VOLUME 30, N UMBER 3, 2014 Immunohematology Journal of Blood Group Serology and Molecular Genetics Volume 30, Number 3, 2014 CONTENTS S EROLO gi C M ETHOD R EV I EW 113 Cold acid elution (ELU Kit II) M. Hinrichs and M.A. Keith E DUC AT I ON A L FORUM C A SE R EPORT 117 A case of masquerading alloantibodies: the value of a multitechnique approach P.M.S. Wennersten and L.J. Sutor B LOOD G ROUP A LLELE R EPORT 121 RHCE variant allele: RHCE*ce254G,733G J.A. Keller, T. Horn, C. Chiappa, C. Melland, C. Vietz, L. Castilho, and M.A. Keller O R igi N A L R EPORT 123 Detection and identification of platelet-associated alloantibodies by a solid-phase modified antigen capture enzyme-linked immunosorbent assay method and its correlation to platelet refractoriness in multiplatelet concentrate–transfused patients N. Jain, R.S. Sarkar, and J. Philip O R igi N A L R EPORT 126 Effects of pH changes of stock normal saline solution on 5 percent red cell suspension G.L. Martin, P.J.M. Caraan, J.J.S. Chua, J.A.L. Crescini, J.M.C. Diokno, C.B.Dlr. Javier, M.K.B.O. Reyes, and R.Y. Soliven C OMMUN I C AT I ON 135 Unusual erythrocyte split chimerism in pregnancy after allogeneic stem cell transplantation M.L. Barjas-Castro, A.C. Vigoritto, F.A. Moretto, and V. Castro 137 A NNOUNCEMENTS 141 A DVERT I SEMENTS 145 I NSTRUCT I ONS FOR A UTHORS E D I TOR - I N -C H I EF E D I TOR ia L B OA RD Sandra Nance, MS, MT(ASCP)SBB Philadelphia, Pennsylvania Patricia Arndt, MT(ASCP)SBB Paul M.
    [Show full text]
  • Platelet Gel for Healing Cutaneous Chronic Wounds
    Transfusion and Apheresis Science 30 (2004) 145–151 intl.elsevierhealth.com/journals/tras Platelet gel for healing cutaneous chronic wounds Giovanni Crovetti a,*, Giovanna Martinelli a, Marwan Issi a, Marilde Barone a, Marco Guizzardi b, Barbara Campanati c, Marco Moroni d, Angelo Carabelli b a Servizio di Immunoematologia e Medicina Trasfusionale, Azienda Ospedaliera ‘‘Ospedale di Circolo di Busto Arsizio’’ Ple Solaro 3, 21052 Busto Arsizio (Varese), Italy b UO di Dermatologia, Azienda Ospedaliera di Gallarate, Lgo Boito 2, 21013 Gallarate (Varese), Italy c UO Chirurgia Vascolare, Azienda Ospedaliera ‘‘Ospedale di Circolo di Busto Arsizio’’ Ple Solaro 3, 21052 Busto Arsizio (Varese), Italy d UO Malattie Infettive, Azienda Ospedaliera ‘‘Ospedale di Circolo di Busto Arsizio’’ Ple Solaro 3, 21052 Busto Arsizio (Varese), Italy Abstract Wound healing is a specific host immune response for restoration of tissue integrity. Experimental studies dem- onstrated an alteration of growth factors activity due to their reduced synthesis, increased degradation and inactivation. In wound healing platelets play an essential role since they are rich of a-granules growth factors (platelet derived growth factor––PDGF; transforming growth factor-b––TGF-b; vascular endothelial growth factor––VEGF). Topical use of platelet gel (PG), hemocomponent obtained from mix of activated platelets and cryoprecipitate, gives the exogenous and in situ adding of growth factors (GF). The hemocomponents are of autologous or homologous origin. We per- formed a technique based on: multicomponent apheretic procedure to obtain plasma rich platelet and cryoprecipitate; manual processing in an open system, in sterile environment, for gel activation. Every step of the gel synthesis was checked by a quality control programme.
    [Show full text]
  • Novel Effectors of Human Platelet Lysate Activity
    EuropeanE Torreggiani Cells et and al. Materials Vol. 28 2014 (pages 137-151) DOI: PL-derived 10.22203/eCM.v028a11 exosomes affect BMSC functions ISSN 1473-2262 in vitro EXOSOMES: NOVEL EFFECTORS OF HUMAN PLATELET LYSATE ACTIVITY E. Torreggiani1,*, F. Perut1, L. Roncuzzi1, N. Zini2,3, SR. Baglìo1 and N. Baldini1,4 1Laboratory for Orthopaedic Pathophysiology and Regenerative Medicine, Istituto Ortopedico Rizzoli, Bologna, Italy 2CNR – National Research Council, Institute of Molecular Genetics, Bologna, Italy 3Laboratory of Muscoloskeletal Cell Biology, Istituto Ortopedico Rizzoli, Bologna, Italy 4Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy Abstract Introduction Despite the popularity of platelet-rich plasma (PRP) and Despite the remarkable ability of bone to undergo extensive platelet lysate (PL) in orthopaedic practice, the mechanism remodelling and regeneration, prompt healing is sometimes of action and the effectiveness of these therapeutic tools impaired if the amount of bone loss is excessive or the are still controversial. So far, the activity of PRP and PL local or systemic conditions are unfavourable. In order to has been associated with different growth factors (GF) increase the chances of cure in the context of regenerative released during platelet degranulation. This study, for the medicine techniques as applied to orthopaedic conditions, first time, identifies exosomes, nanosized vesicles released new approaches based on platelet derivatives, such as in the extracellular compartment by a number of elements, platelet-rich plasma (PRP) and platelet lysate (PL), including platelets, as one of the effectors of PL activity. have attracted the attention of several investigators. PRP Exosomes were isolated from human PL by differential and PL contain a high concentration of growth factors ultracentrifugation, and analysed by electron microscopy (GF), cytokines and molecules that actively contribute and Western blotting.
    [Show full text]